A leading European firm of Intellectual Property specialists

We provide commercially focused, creative advice on obtaining, enforcing and exploiting intellectual property rights including patents, trade marks and designs to a wide range of clients who enjoy our straight forward approach and flexible working practices.

SPOTLIGHT ON...

150 Years of Innovation

From its small beginnings in 1867, Mewburn Ellis has grown into a vibrant, outward-looking partnership with innovation at its core. As science and technology continue to transform the way we live, we look forward to a future as positive and successful as our past.

Brexit

It's business as usual for Mewburn Ellis despite the decision for the UK to end its membership of the EU. We consider the effect of the decision on intellectual property.

Transport

Our experience advising a wide range of clients, from UK-based component manufacturers to multi-national vehicle manufacturers, means we can help you develop an appropriate IP strategy to meet your business needs.

MEDTECH

With a medtech team including patent attorneys drawn from all technical disciplines, you can rest assured that you will be working with a specialist that truly understands your technology.

PHARMACEUTICAL

The worldwide recognition achieved by our large pharmaceutical team will give you the confidence that your commercially valuable intellectual property is in the best hands.

FOOD & BEVERAGE

Many restaurateur, food producer and brewery clients have enjoyed considerable success working with our trade mark and patent attorneys to protect their brands and innovations.

OUR OFFICES

LONDON

t: +44 (0)20 7776 5300

BRISTOL

t: +44 (0)117 945 1234

CAMBRIDGE

t: +44 (0)1223 420383

MANCHESTER

t: +44 (0)161 247 7722

View map & contact details

LATEST NEWS & EVENTS

F-star enters into strategic collaboration to develop bispecific antibodies in immuno-oncology

F-star, a biopharmaceutical company developing bispecific antibody immuno-oncology products, has announced a new partnership with a leading science and technology company. This new strategic collaboration will focus on the development and commercialisation of five bispecific immuno-oncology antibodies.

UK Supreme Court rules on File Wrapper Estoppel and Equivalents

On 12 July, 2017 an important judgement was handed down by the UK Supreme Court in the case of Eli Lilly v Actavis UK. The reasoning in the decision is significant for UK law in two legal areas: file wrapper estoppel and doctrine of equivalents.